{"title":"The Major Conditions Strategy: implications for GI nurses","authors":"P. Harrison","doi":"10.12968/gasn.2024.22.3.166","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.3.166","url":null,"abstract":"With the government's launch of the The Major Conditions Strategy, Penny Harrison considers the effects it may have on GI nurses in practice","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"17 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140754149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-02DOI: 10.12968/gasn.2024.22.3.133
Tom Allaway
{"title":"A new digital tool to help manage Crohn's and colitis","authors":"Tom Allaway","doi":"10.12968/gasn.2024.22.3.133","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.3.133","url":null,"abstract":"","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"18 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140753970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.12968/gasn.2024.22.sup3.s3
Abdullah Abbasi, Shyam Menon
{"title":"Implementing AI in endoscopy","authors":"Abdullah Abbasi, Shyam Menon","doi":"10.12968/gasn.2024.22.sup3.s3","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.sup3.s3","url":null,"abstract":"","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"27 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140786579","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.12968/gasn.2024.22.sup3.s6
Laurence B Lovat
The use of artificial intelligence (AI) is rapidly advancing in gastroenterology, most notably in the area of endoscopy, but also more widely throughout the speciality. This article reviews what AI is, how it works and some of the key advances it is bringing. AI can already improve patient triage so that resources can be better targeted at sick patients. In endoscopy, AI can improve the detection of polyps during colonoscopy and the accuracy of diagnosis, while in Barrett's oesophagus, it can improve the detection of pre-cancerous dysplasia so that all endoscopists can emulate the performance of world-class experts. Systems are being developed to automate the assessment of bowel preparation quality and report writing. The power of novel generative AI such as ChatGPT could drive major improvements in communication between busy clinicians and patients. Healthcare professionals need to ensure they understand how to manage the ‘black-box’ that is AI.
{"title":"Artificial intelligence in gastroenterology: where are we and where are we going?","authors":"Laurence B Lovat","doi":"10.12968/gasn.2024.22.sup3.s6","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.sup3.s6","url":null,"abstract":"The use of artificial intelligence (AI) is rapidly advancing in gastroenterology, most notably in the area of endoscopy, but also more widely throughout the speciality. This article reviews what AI is, how it works and some of the key advances it is bringing. AI can already improve patient triage so that resources can be better targeted at sick patients. In endoscopy, AI can improve the detection of polyps during colonoscopy and the accuracy of diagnosis, while in Barrett's oesophagus, it can improve the detection of pre-cancerous dysplasia so that all endoscopists can emulate the performance of world-class experts. Systems are being developed to automate the assessment of bowel preparation quality and report writing. The power of novel generative AI such as ChatGPT could drive major improvements in communication between busy clinicians and patients. Healthcare professionals need to ensure they understand how to manage the ‘black-box’ that is AI.","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"67 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140794237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.12968/gasn.2024.22.sup3.s1
Riadh Jazrawi
Ulcerative colitis (UC) is characterised by chronic mucosal inflammation primarily in the colon. Guidelines recommend mesalazine as first-line therapy for induction of maintenance in mild-to-moderate Ulcerative colitis. Patients' preferences, response to treatment, site and extent of inflammation and cost are important considerations when selecting mesalazine therapy. This article reviews mesalazine's role in ulcerative colitis and explores the factors to consider when optimising mesalazine-based therapy. Up to two-thirds of patients fail to respond to induction therapy within 8 weeks, thereby prompting a switch of formulations or escalation to oral corticosteroids. While there are no major variations in efficacy, different mesalazine formulations are not interchangeable because of differences in mode of drug delivery, site of drug release and excipients. Switching mesalazine products before escalating therapy may, therefore, spare patients from wider side effects and higher costs. Optimising mesalazine-based therapy requires individualised treatment plans based on patient preferences, site and extent of inflammation, response to treatment and potential side effects. An algorithm exists to guide the selection of alternative mesalazine formulations when required.
{"title":"Can more be done to optimise the effect of mesalazine for IBD patients with mild to moderate ulcerative colitis?","authors":"Riadh Jazrawi","doi":"10.12968/gasn.2024.22.sup3.s1","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.sup3.s1","url":null,"abstract":"Ulcerative colitis (UC) is characterised by chronic mucosal inflammation primarily in the colon. Guidelines recommend mesalazine as first-line therapy for induction of maintenance in mild-to-moderate Ulcerative colitis. Patients' preferences, response to treatment, site and extent of inflammation and cost are important considerations when selecting mesalazine therapy. This article reviews mesalazine's role in ulcerative colitis and explores the factors to consider when optimising mesalazine-based therapy. Up to two-thirds of patients fail to respond to induction therapy within 8 weeks, thereby prompting a switch of formulations or escalation to oral corticosteroids. While there are no major variations in efficacy, different mesalazine formulations are not interchangeable because of differences in mode of drug delivery, site of drug release and excipients. Switching mesalazine products before escalating therapy may, therefore, spare patients from wider side effects and higher costs. Optimising mesalazine-based therapy requires individualised treatment plans based on patient preferences, site and extent of inflammation, response to treatment and potential side effects. An algorithm exists to guide the selection of alternative mesalazine formulations when required.","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"86 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140766717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.12968/gasn.2024.22.sup3.s4
P. Harrison
A brief overview of recently published articles on endoscopy, this month focusing on artificial intelligence
最近发表的有关内窥镜的文章概览，本月重点关注人工智能
{"title":"Study scope","authors":"P. Harrison","doi":"10.12968/gasn.2024.22.sup3.s4","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.sup3.s4","url":null,"abstract":"A brief overview of recently published articles on endoscopy, this month focusing on artificial intelligence","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"15 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140797085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-04-01DOI: 10.12968/gasn.2024.22.sup3.s14
Adele Wargen
The British Society for Gastroenterology (BSG) guidelines for post-polypectomy and post-cancer-resection surveillance were changed in October 2020, essentially excluding a large proportion of patients awaiting a surveillance colonoscopy as they now no longer fit the criteria for surveillance. To audit the colonoscopy surveillance waiting list at the Wye Valley Trust to ascertain patient appropriateness for colonoscopy under the new BSG guidelines. A practitioner-led colonoscopy surveillance clinic led by a clinical endoscopist was set up to audit the colonoscopy surveillance waiting list of over 1200 patients. The aim was to clinically assess each patient against the guidelines and determine discharge from, or continuation of, the surveillance pathway for each patient. The patients were then offered outpatient clinic appointments where fitness was assessed and appropriate investigations were finalised. Patient numbers on the colonoscopy surveillance waiting list were reduced by nearly 50%, with waiting times down to 0 weeks, by facilitating practitioner-led pre-assessment and outpatient clinics, all while saving Weston General Hospital almost £300000 in the initial 9 months. The new colonoscopy surveillance guidelines presented an opportunity to audit and evaluate the colonoscopy guidelines in the Wye Valley Trust. The facilitation of a clinical endoscopist committed time to implement new pre-assessment processes and outpatient clinics, this process allowed the discharge of almost 50% of patients upon the colonoscopy surveillance waiting list, it created extra colonoscopy capacity for 2 week wait and urgent colonoscopies, while generating a positive financial implication for the trust.
{"title":"How practitioner-led colonoscopy surveillance management improves productivity while saving money","authors":"Adele Wargen","doi":"10.12968/gasn.2024.22.sup3.s14","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.sup3.s14","url":null,"abstract":"The British Society for Gastroenterology (BSG) guidelines for post-polypectomy and post-cancer-resection surveillance were changed in October 2020, essentially excluding a large proportion of patients awaiting a surveillance colonoscopy as they now no longer fit the criteria for surveillance. To audit the colonoscopy surveillance waiting list at the Wye Valley Trust to ascertain patient appropriateness for colonoscopy under the new BSG guidelines. A practitioner-led colonoscopy surveillance clinic led by a clinical endoscopist was set up to audit the colonoscopy surveillance waiting list of over 1200 patients. The aim was to clinically assess each patient against the guidelines and determine discharge from, or continuation of, the surveillance pathway for each patient. The patients were then offered outpatient clinic appointments where fitness was assessed and appropriate investigations were finalised. Patient numbers on the colonoscopy surveillance waiting list were reduced by nearly 50%, with waiting times down to 0 weeks, by facilitating practitioner-led pre-assessment and outpatient clinics, all while saving Weston General Hospital almost £300000 in the initial 9 months. The new colonoscopy surveillance guidelines presented an opportunity to audit and evaluate the colonoscopy guidelines in the Wye Valley Trust. The facilitation of a clinical endoscopist committed time to implement new pre-assessment processes and outpatient clinics, this process allowed the discharge of almost 50% of patients upon the colonoscopy surveillance waiting list, it created extra colonoscopy capacity for 2 week wait and urgent colonoscopies, while generating a positive financial implication for the trust.","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"29 6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140763230","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"England's Chief Nursing Officer 7Ps: a new nursing framework","authors":"P. Harrison","doi":"10.12968/gasn.2024.22.2.124","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.2.124","url":null,"abstract":"Penny Harrison explores a new nursing framework, launched in November 2023, colloquially termed the ‘7Ps’","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"44 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140267672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-03-02DOI: 10.12968/gasn.2024.22.2.84
Sorice Vittoria, G. Mortimore
Sorice Vittoria and Gerri Mortimore look into the impact of microagressions and racial bias that currently exist across healthcare and how they can be tackled
Sorice Vittoria 和 Gerri Mortimore 探讨了目前存在于医疗保健领域的微言和种族偏见的影响，以及如何解决这些问题。
{"title":"Burning out in silence: unmasking the impact of microaggression and racial bias in the workplace","authors":"Sorice Vittoria, G. Mortimore","doi":"10.12968/gasn.2024.22.2.84","DOIUrl":"https://doi.org/10.12968/gasn.2024.22.2.84","url":null,"abstract":"Sorice Vittoria and Gerri Mortimore look into the impact of microagressions and racial bias that currently exist across healthcare and how they can be tackled","PeriodicalId":52494,"journal":{"name":"Gastrointestinal Nursing","volume":"37 12","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140267732","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：